← Leaderboards
Alan W Partin
Johns Hopkins University
$6,119,110
Attributed
$6,119,110
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $861.3K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$6,119,110 · 2
By mechanism
U01$6,119,110 · 1
P50$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- David Sidransky$59,922,938
- Martin G Pomper$38,517,075
- James G. Herman$8,069,882
- Daniel W Chan$17,758,540
- Kenneth J. Pienta$43,861,680
Others in their field
Top investigators on “Biomarker”
- David R. Weir · University Of Michigan At Ann Arbor$368,126,077
- Leonard Freedman · Leidos Biomedical Research, Inc.$248,231,562
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$217,859,034
- Ralph Parchment · Leidos Biomedical Research, Inc.$186,322,680
- Randall J Bateman · Washington University$182,177,358
- Paul S. Aisen · Cognition Therapeutics, Inc.$182,141,353
Research focus
BiomarkerNeoplasm /Cancer DiagnosisTissue Resource /RegistryProstate NeoplasmsNeoplasm /Cancer EpidemiologyComputer Assisted DiagnosisCancer Registry /ResourceProstate Specific AntigenNeoplasm /Cancer Classification /StagingImmunocytochemistryCooperative StudyPrognosisHuman SubjectClinical ResearchKallikreinsLongitudinal Human StudyArtificial IntelligenceMaleDeath RateCoupledBiopsyIndustryArchivesMission
Grant awards (13)
Development/Clinical Validation Markers for Prostate Ca$191,606
U01 · FY2010 · CA · contact PI
Development/Clinical Validation Markers for Prostate Ca$718,527
U01 · FY2009 · CA · contact PI
Development/Clinical Validation Markers for Prostate Ca$702,609
U01 · FY2008 · CA · contact PI
Development/Clinical Validation Markers for Prostate Ca$684,827
U01 · FY2007 · CA · contact PI
Development/Clinical Validation Markers for Prostate Ca$686,983
U01 · FY2006 · CA · contact PI
Development/Clinical Validation Markers for Prostate Ca$861,307
U01 · FY2005 · CA
CLINICAL AND EPIDEMIOLOGICAL CENTER--PROSTATE CANCER$472,484
U01 · FY2004 · CA
CLINICAL AND EPIDEMIOLOGICAL CENTER--PROSTATE CANCER$458,243
U01 · FY2003 · CA
Core--Biomarker development$0
P50 · FY2003 · CA
CLINICAL AND EPIDEMIOLOGICAL CENTER--PROSTATE CANCER$443,574
U01 · FY2002 · CA
CLINICAL AND EPIDEMIOLOGICAL CENTER--PROSTATE CANCER$97,571
U01 · FY2002 · CA
CLINICAL AND EPIDEMIOLOGICAL CENTER--PROSTATE CANCER$430,378
U01 · FY2001 · CA
CLINICAL AND EPIDEMIOLOGICAL CENTER--PROSTATE CANCER$371,001
U01 · FY2000 · CA